{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:04Z","timestamp":1793381044424,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23264-4","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:52:42Z","timestamp":1748937162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiological characteristics of human papillomavirus in Guangzhou, China\u2014A retrospective analysis of 76,898 cases"],"prefix":"10.1186","volume":"25","author":[{"given":"Shiyuan","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"23264_CR1","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/cncr.33795","volume":"127","author":"S Lin","year":"2021","unstructured":"Lin S, Gao K, Gu S, You L, Qian S, Tang M, et al. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. 2021;127:4030\u20139. https:\/\/doi.org\/10.1002\/cncr.33795.","journal-title":"Cancer"},{"key":"23264_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/657321","volume":"202","author":"L Bruni","year":"2010","unstructured":"Bruni L, Diaz M, Castellsagu\u00e9 X, Ferrer E, Bosch FX, De Sanjos\u00e9 S. Cervical human papillomavirus prevalence in 5 continents: Meta-Analysis of 1 million women with normal cytological findings. J INFECT DIS. 2010;202:1789\u201399. https:\/\/doi.org\/10.1086\/657321.","journal-title":"J INFECT DIS"},{"key":"23264_CR3","doi-asserted-by":"publisher","first-page":"e2537","DOI":"10.1002\/rmv.2537","volume":"34","author":"J Wolf","year":"2024","unstructured":"Wolf J, Kist LF, Pereira SB, Quessada MA, Petek H, Pille A, et al. Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol. 2024;34:e2537. https:\/\/doi.org\/10.1002\/rmv.2537.","journal-title":"Rev Med Virol"},{"key":"23264_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12889-017-4651-7","volume":"18","author":"C Wu","year":"2018","unstructured":"Wu C, Zhu X, Kang Y, Cao Y, Lu P, Zhou W, et al. Epidemiology of humanpapilloma virus infection among women in Fujian, China. BMC Public Health. 2018;18:95. https:\/\/doi.org\/10.1186\/s12889-017-4651-7.","journal-title":"BMC Public Health"},{"key":"23264_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12985-021-01676-z","volume":"18","author":"X Yan","year":"2021","unstructured":"Yan X, Shen L, Xiao Y, Wang Q, Li F, Qian Y. Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016\u20132020. Virol J. 2021;18:208. https:\/\/doi.org\/10.1186\/s12985-021-01676-z.","journal-title":"Virol J"},{"key":"23264_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jiph.2023.07.013","volume":"16","author":"J Huiyun","year":"2023","unstructured":"Huiyun J, Jie D, Huan W, Yuebo Y, Xiaomao L. Prevalence and characteristics of cervical human papillomavirus genotypes and cervical lesions among 58630 women from Guangzhou, China. J Infect Public Health. 2023;16:1531\u20136. https:\/\/doi.org\/10.1016\/j.jiph.2023.07.013.","journal-title":"J Infect Public Health"},{"key":"23264_CR7","doi-asserted-by":"publisher","first-page":"e22581","DOI":"10.1002\/jcla.22581","volume":"32","author":"F Xiang","year":"2018","unstructured":"Xiang F, Guan Q, Liu X, Xiao H, Xia Q, Liu X, et al. Distribution characteristics of different human papillomavirus genotypes in women in Wuhan, China. Clin Lab Anal. 2018;32:e22581. https:\/\/doi.org\/10.1002\/jcla.22581.","journal-title":"Clin Lab Anal"},{"key":"23264_CR8","doi-asserted-by":"publisher","first-page":"15128","DOI":"10.1038\/s41598-021-94635-1","volume":"11","author":"B Gao","year":"2021","unstructured":"Gao B, Liou Y-L, Yu Y, Zou L, Li W, Huang H, et al. The characteristics and risk factors of human papillomavirus infection: an outpatient population-based study in Changsha, Hunan. Sci Rep. 2021;11:15128. https:\/\/doi.org\/10.1038\/s41598-021-94635-1.","journal-title":"Sci Rep"},{"key":"23264_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12985-024-02447-2","volume":"21","author":"J-P Hu","year":"2024","unstructured":"Hu J-P, Wang J-L, Li Y, Feng Y, Tian C-Q, Zhang G-H, et al. Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China. Virol J. 2024;21:176. https:\/\/doi.org\/10.1186\/s12985-024-02447-2.","journal-title":"Virol J"},{"key":"23264_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1186\/s12905-021-01504-0","volume":"21","author":"W Lin","year":"2021","unstructured":"Lin W, Zhang Q, Chen Y, Chen L, Dong B, Sun P. The prevalence of human papillomavirus and bacterial vaginosis among young women in China: a cross-sectional study. BMC Women\u2019s Health. 2021;21:409. https:\/\/doi.org\/10.1186\/s12905-021-01504-0.","journal-title":"BMC Women\u2019s Health"},{"key":"23264_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12985-022-01775-5","volume":"19","author":"D Feng","year":"2022","unstructured":"Feng D, Wei S, Chen J, Yu Z, Lhamo Y, Wang H, et al. Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan autonomous region, China. Virol J. 2022;19:46. https:\/\/doi.org\/10.1186\/s12985-022-01775-5.","journal-title":"Virol J"},{"key":"23264_CR12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11886","author":"X Yan","year":"2020","unstructured":"Yan X, Huang Y, Zhang M, Hu X, Li K, Jing M. Prevalence of human papillomavirus infection and type distribution among Uyghur females in Xinjiang, Northwest China. Oncol Lett. 2020. https:\/\/doi.org\/10.3892\/ol.2020.11886.","journal-title":"Oncol Lett"},{"key":"23264_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12985-023-01959-7","volume":"20","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo N, Li B, Shang E, Wang J, Zhang M, et al. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020. Virol J. 2023;20:11. https:\/\/doi.org\/10.1186\/s12985-023-01959-7.","journal-title":"Virol J"},{"key":"23264_CR14","doi-asserted-by":"crossref","first-page":"e19596","DOI":"10.1371\/journal.pone.0019596","volume":"6","author":"SS Liu","year":"2011","unstructured":"Liu SS, Chan KYK, Leung RCY, Chan KKL, Fai K, Luk MHM, et al. Prevalence and risk factors of human papillomavirus (HPV) infection in Southern Chinese Women\u2013 A Population-Based study. PLoS ONE. 2011;6:e19596.","journal-title":"PLoS ONE"},{"key":"23264_CR15","doi-asserted-by":"publisher","first-page":"e2176009","DOI":"10.1080\/22221751.2023.2176009","volume":"12","author":"X Yang","year":"2023","unstructured":"Yang X, Li Y, Tang Y, Li Z, Wang S, Luo X, et al. Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021. Emerg Microbes Infections. 2023;12:e2176009. https:\/\/doi.org\/10.1080\/22221751.2023.2176009.","journal-title":"Emerg Microbes Infections"},{"key":"23264_CR16","doi-asserted-by":"publisher","first-page":"13353","DOI":"10.1038\/s41598-022-17632-y","volume":"12","author":"W Huang","year":"2022","unstructured":"Huang W, Xu H, Hu H, Zhang D, Liu Y, Guo Y, et al. The prevalence of human papillomavirus among women in Northern Guangdong Province of China. Sci Rep. 2022;12:13353. https:\/\/doi.org\/10.1038\/s41598-022-17632-y.","journal-title":"Sci Rep"},{"key":"23264_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.46234\/ccdcw2022.219","volume":"4","author":"D Shao","year":"2022","unstructured":"Shao D, Xia X, Liu H, Huang M, Yu J, He J, et al. Prevalence of High-Risk human papillomavirus by subtypes among rural women aged 35\u201364 Years \u2014 Guangzhou City, Guangdong Province, China, 2019\u20132021. China CDC Wkly. 2022;4:1088\u201391. https:\/\/doi.org\/10.46234\/ccdcw2022.219.","journal-title":"China CDC Wkly"},{"key":"23264_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jiph.2020.11.011","volume":"14","author":"M Li","year":"2021","unstructured":"Li M, Liu T, Luo G, Sun X, Hu G, Lu Y, et al. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007\u20132018: A retrospective cohort study. J Infect Public Health. 2021;14:42\u20139. https:\/\/doi.org\/10.1016\/j.jiph.2020.11.011.","journal-title":"J Infect Public Health"},{"key":"23264_CR19","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/sextrans-2017-053412","volume":"94","author":"X Ma","year":"2018","unstructured":"Ma X, Wang Q, Ong JJ, Fairley CK, Su S, Peng P, et al. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sex Transm Infect. 2018;94:434\u201342. https:\/\/doi.org\/10.1136\/sextrans-2017-053412.","journal-title":"Sex Transm Infect"},{"key":"23264_CR20","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/1055-9965.2271.13.12","volume":"13","author":"C Ferreccio","year":"2004","unstructured":"Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJF, Meijer CJLM, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev. 2004;13:2271\u20136.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"23264_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.21147\/j.issn.1000-9604.2019.04.10","volume":"31","author":"S Zhao","year":"2019","unstructured":"Zhao S, Zhao X, Hu S, Lu J, Duan X, Zhang X, et al. Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China. Chin J Cancer Res. 2019;31:663\u201372. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.04.10.","journal-title":"Chin J Cancer Res"},{"key":"23264_CR22","doi-asserted-by":"publisher","first-page":"e5254","DOI":"10.1590\/1414-431X20165254","volume":"49","author":"Z Baloch","year":"2016","unstructured":"Baloch Z, Yuan T, Yindi S, Feng Y, Tai W, Liu Y, et al. Prevalence of genital human papillomavirus among rural and urban populations in Southern Yunnan Province, China. Braz J Med Biol Res. 2016;49:e5254. https:\/\/doi.org\/10.1590\/1414-431X20165254.","journal-title":"Braz J Med Biol Res"},{"key":"23264_CR23","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1080\/21645515.2019.1611157","volume":"15","author":"LP Wong","year":"2019","unstructured":"Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccines Immunotherapeutics. 2019;15:1533\u201340. https:\/\/doi.org\/10.1080\/21645515.2019.1611157.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"23264_CR24","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1016\/j.vaccine.2015.06.052","volume":"33","author":"T Wu","year":"2015","unstructured":"Wu T, Hu Y-M, Li J, Chu K, Huang S-J, Zhao H, et al. Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus (type 16 and 18) vaccine: A randomized controlled phase 2 clinical trial. Vaccine. 2015;33:3940\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.052.","journal-title":"Vaccine"},{"key":"23264_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","volume":"13","author":"CM Wheeler","year":"2012","unstructured":"Wheeler CM, Castellsagu\u00e9 X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol. 2012;13:100\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(11)70287-X.","journal-title":"Lancet Oncol"},{"key":"23264_CR26","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/jmv.25520","volume":"91","author":"G Luo","year":"2019","unstructured":"Luo G, Sun X, Li M, Liu T, Hu G, He Y, et al. Cervical human papillomavirus among women in Guangdong, China 2008-2017: implication for screening and vaccination. J Med Virol. 2019;91:1856\u201365. https:\/\/doi.org\/10.1002\/jmv.25520.","journal-title":"J Med Virol"},{"key":"23264_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2016.118","volume":"5","author":"F Wei","year":"2016","unstructured":"Wei F, Yin K, Wu X, Lan J, Huang S, Sheng W, et al. Human papillomavirus prevalence and associated factors in women and men in South China: a population-based study. Emerg Microbes Infections. 2016;5:1\u20138. https:\/\/doi.org\/10.1038\/emi.2016.118.","journal-title":"Emerg Microbes Infections"},{"key":"23264_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/jmv.24888","volume":"90","author":"X Wang","year":"2018","unstructured":"Wang X, Ji Y, Li J, Dong H, Zhu B, Zhou Y, et al. Prevalence of human papillomavirus infection in women in the autonomous region of inner Mongolia: A population-based study of a Chinese ethnic minority. J Med Virol. 2018;90:148\u201356. https:\/\/doi.org\/10.1002\/jmv.24888.","journal-title":"J Med Virol"},{"key":"23264_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12985-020-01352-8","volume":"17","author":"H Li","year":"2020","unstructured":"Li H, Li P, Huang L, Sun L, Ren H, Li P. Prevalence characteristics of cervical human papillomavirus (HPV) infection in the Zhoupu district, Shanghai City, China. Virol J. 2020;17:84. https:\/\/doi.org\/10.1186\/s12985-020-01352-8.","journal-title":"Virol J"},{"key":"23264_CR30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.4103\/jcrt.jcrt_224_23","volume":"20","author":"Y Yu","year":"2024","unstructured":"Yu Y, Hao J, Mohamed SB, Fu S, Zhao F, Qiao Y. The prevalence of multiple or single HPV infection and genotype distribution in healthy Chinese women: A systemic review. J Cancer Res Ther. 2024;20:1265\u201373. https:\/\/doi.org\/10.4103\/jcrt.jcrt_224_23.","journal-title":"J Cancer Res Ther"},{"key":"23264_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00404-020-05787-w","volume":"302","author":"J Zhang","year":"2020","unstructured":"Zhang J, Cheng K, Wang Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis. Arch Gynecol Obstet. 2020;302:1329\u201337. https:\/\/doi.org\/10.1007\/s00404-020-05787-w.","journal-title":"Arch Gynecol Obstet"},{"key":"23264_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12985-020-01366-2","volume":"17","author":"Q Luo","year":"2020","unstructured":"Luo Q, Jiang N, Wu Q, Wang J, Zhong J. Prevalence and genotype distribution of HPV and cervical pathological results in Sichuan Province, China: a three years surveys prior to mass HPV vaccination. Virol J. 2020;17:100. https:\/\/doi.org\/10.1186\/s12985-020-01366-2.","journal-title":"Virol J"},{"key":"23264_CR33","first-page":"666","volume":"25","author":"X Wang","year":"2023","unstructured":"Wang X, Jiang H, Li X. Distribution of human papillomavirus types in cervical cancer population. J Chin Phys. 2023;25:666\u20139.","journal-title":"J Chin Phys"},{"key":"23264_CR34","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382:889\u201399. https:\/\/doi.org\/10.1016\/S0140-6736(13)60022-7.","journal-title":"Lancet"},{"key":"23264_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/sj.bjc.6600442","volume":"87","author":"M Molano","year":"2002","unstructured":"Molano M, Posso H, Weiderpass E, Van Den Brule AJC, Ronderos M, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324\u201333. https:\/\/doi.org\/10.1038\/sj.bjc.6600442.","journal-title":"Br J Cancer"},{"key":"23264_CR36","doi-asserted-by":"publisher","first-page":"1210253","DOI":"10.3389\/fpubh.2023.1210253","volume":"11","author":"J Hou","year":"2023","unstructured":"Hou J, Zeng M, Liu C, Xie B, Li Y, Wu L, et al. Cervical HPV infection in Yueyang, China: a cross-sectional study of 125,604 women from 2019 to 2022. Front Public Health. 2023;11:1210253. https:\/\/doi.org\/10.3389\/fpubh.2023.1210253.","journal-title":"Front Public Health"},{"key":"23264_CR37","doi-asserted-by":"publisher","first-page":"e0210311","DOI":"10.1371\/journal.pone.0210311","volume":"14","author":"L Jiang","year":"2019","unstructured":"Jiang L, Tian X, Peng D, Zhang L, Xie F, Bi C, et al. HPV prevalence and genotype distribution among women in Shandong Province, China: analysis of 94,489 HPV genotyping results from Shandong\u2019s largest independent pathology laboratory. PLoS ONE. 2019;14:e0210311.","journal-title":"PLoS ONE"},{"key":"23264_CR38","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/ajcp\/aqab181","volume":"157","author":"Z Zeng","year":"2022","unstructured":"Zeng Z, Austin RM, Wang L, Guo X, Zeng Q, Zheng B, et al. Nationwide prevalence and genotype distribution of High-Risk human papillomavirus infection in China. Am J Clin Pathol. 2022;157:718\u201323. https:\/\/doi.org\/10.1093\/ajcp\/aqab181.","journal-title":"Am J Clin Pathol"},{"key":"23264_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/LGT.0000000000000487","volume":"23","author":"AD Iacobone","year":"2019","unstructured":"Iacobone AD, Bottari F, Radice D, Preti EP, Franchi D, Vidal Urbinati AM, et al. Distribution of High-Risk human papillomavirus genotypes and multiple infections in preneoplastic and neoplastic cervical lesions of unvaccinated women: A Cross-sectional study. J Low Genit Tract Dis. 2019;23:259\u201364. https:\/\/doi.org\/10.1097\/LGT.0000000000000487.","journal-title":"J Low Genit Tract Dis"},{"key":"23264_CR40","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.24875\/GMM.M22000679","volume":"158","author":"B Gonz\u00e1lez-Yebra","year":"2022","unstructured":"Gonz\u00e1lez-Yebra B, Mojica-Larrea M, Alonso R, Gonz\u00e1lez AL, Romero-Morelos P, Taniguchi-Ponciano K, et al. HPV infection profile in cervical lesions. GMM. 2022;158:9622. https:\/\/doi.org\/10.24875\/GMM.M22000679.","journal-title":"GMM"},{"key":"23264_CR41","doi-asserted-by":"publisher","first-page":"101389","DOI":"10.1016\/j.jgo.2022.10.004","volume":"14","author":"J Huiyun","year":"2023","unstructured":"Huiyun J, Huixia Y, Xiaomao L, Yu Z. Time trends assessment of cervical cancer characteristics in Guangzhou, 2010\u20132021: is the age at diagnosis increasing over time? J Geriatric Oncol. 2023;14:101389. https:\/\/doi.org\/10.1016\/j.jgo.2022.10.004.","journal-title":"J Geriatric Oncol"},{"key":"23264_CR42","doi-asserted-by":"publisher","unstructured":"Huiyun J, Yuebo Y, Xiaomao L. Prevalence of human papillomavirus and cervical lesions among elderly women: an unignored challenge to cervical cancer prevention. Ann Med https:\/\/doi.org\/10.1080\/07853890.2024.2404548","DOI":"10.1080\/07853890.2024.2404548"},{"key":"23264_CR43","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s12879-023-08634-w","volume":"23","author":"Q Luo","year":"2023","unstructured":"Luo Q, Zeng X, Luo H, Pan L, Huang Y, Zhang H, et al. Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions. BMC Infect Dis. 2023;23:667. https:\/\/doi.org\/10.1186\/s12879-023-08634-w.","journal-title":"BMC Infect Dis"},{"key":"23264_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ijgo.13406","volume":"152","author":"Y Li","year":"2021","unstructured":"Li Y, Wang H, Zhang Y, Jing X, Wu N, Hou Y, et al. Correlation between multi-type human papillomavirus infections and viral loads and the cervical pathological grade. Int J Gynaecol Obstet. 2021;152:96\u2013102. https:\/\/doi.org\/10.1002\/ijgo.13406.","journal-title":"Int J Gynaecol Obstet"},{"key":"23264_CR45","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jmv.25331","volume":"91","author":"M Li","year":"2019","unstructured":"Li M, Du X, Lu M, Zhang W, Sun Z, Li L, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J Med Virol. 2019;91:473\u201381. https:\/\/doi.org\/10.1002\/jmv.25331.","journal-title":"J Med Virol"},{"key":"23264_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8130373","volume":"2022","author":"F Zhong","year":"2022","unstructured":"Zhong F, Yu T, Ma X, Wang S, Cong Q, Tao X. Extensive HPV genotyping reveals high association between multiple infections and cervical lesions in Chinese women. Dis Markers. 2022;2022:1\u20139. https:\/\/doi.org\/10.1155\/2022\/8130373.","journal-title":"Dis Markers"},{"key":"23264_CR47","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.1002\/jmv.28062","volume":"94","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li S, Zheng J, Xue H, Chen J, Zheng X. Prevalence of multiple human papillomavirus infections and association with cervical lesions among outpatients in Fujian, China: A cross-sectional study. J Med Virol. 2022;94:6028\u201336. https:\/\/doi.org\/10.1002\/jmv.28062.","journal-title":"J Med Virol"},{"key":"23264_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"E-M De Villiers","year":"2004","unstructured":"De Villiers E-M, Fauquet C, Broker TR, Bernard H-U, Zur Hausen H. Classification of papillomaviruses. Virology. 2004;324:17\u201327. https:\/\/doi.org\/10.1016\/j.virol.2004.03.033.","journal-title":"Virology"},{"key":"23264_CR49","doi-asserted-by":"publisher","first-page":"e35736","DOI":"10.1016\/j.heliyon.2024.e35736","volume":"10","author":"D Zhou","year":"2024","unstructured":"Zhou D, Xue J, Sun Y, Zhu L, Zhao M, Cui M, et al. Patterns of single and multiple HPV infections in female: A systematic review and meta-analysis. Heliyon. 2024;10:e35736. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35736.","journal-title":"Heliyon"},{"key":"23264_CR50","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s12879-024-09693-3","volume":"24","author":"Q Luo","year":"2024","unstructured":"Luo Q, Zhang H, Zeng X, Han N, Ma Z, Luo H. HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study. BMC Infect Dis. 2024;24:804. https:\/\/doi.org\/10.1186\/s12879-024-09693-3.","journal-title":"BMC Infect Dis"},{"key":"23264_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.puhe.2016.01.021","volume":"135","author":"C Shu","year":"2016","unstructured":"Shu C, Fu A, Lu J, Yin M, Chen Y, Qin T, et al. Association between age at first sexual intercourse and knowledge, attitudes and practices regarding reproductive health and unplanned pregnancy: a cross-sectional study. Public Health. 2016;135:104\u201313. https:\/\/doi.org\/10.1016\/j.puhe.2016.01.021.","journal-title":"Public Health"},{"key":"23264_CR52","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","volume":"35","author":"Human papillomavirus vaccines","year":"2017","unstructured":"Human papillomavirus vaccines. WHO position paper, May 2017-Recommendations. Vaccine. 2017;35:5753\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.069.","journal-title":"Vaccine"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23264-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23264-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:52:43Z","timestamp":1748937163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23264-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23264"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23264-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Third Affiliated Hospital, Sun Yat-sen University (Approval Number: No. II2024-112-01). As this was a retrospective analysis based on anonymized data, the requirement for informed consent was deemed unnecessary under Article 32 of the Measures for the Ethical Review of Life Sciences and Medical Research Involving Humans (2023, China). All procedures and analyses involving human participants adhered to the ethical principles of the Declaration of Helsinki and were conducted in accordance with relevant national and institutional regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2061"}}